🕵️ Synergy CHC Corp. ($SNYR)
SEC insider & ownership activity, last 12 months · CIK 1562733 · every row links its SEC filing
Over the last 12 months insiders bought $80K with no open-market selling against it. Ross Jack bought $80K (Jun–Jul). Knight Therapeutics Inc. added 17.0% → 19.9%. One red-flag 8-K in the window: Delisting notice (3.01), May 15, 2026.
Insider flow
1 buyer, $80K (24 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ross Jack | 24 | $80K | 0 | – | Jul 30, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Knight Therapeutics Inc. | 19.9% | 13G | Jun 13, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Delisting notice (3.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 24, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 24, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Other events (8.01) | Feb 27, 2026 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 22, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 25, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 25, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 18, 2025 | filing ↗ |
| Earnings (2.02) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |